NF- κ B Expression in Mononuclear Cells of Patients with Sepsis Resembles That Observed in Lipopolysaccharide Tolerance

MINOU ADIB-CONQUY; CHRISTOPHE ADRIE; Pierre Moine; Karim Asehnoune; CATHERINE FITTING; Michael R. Pinsky; JEAN-FRANÇOIS DHAINAUT; JEAN-MARC CAVAILLON

doi:10.1164/ajrccm.162.5.2003058

journal article Nov 01, 2000

NF- κ B Expression in Mononuclear Cells of Patients with Sepsis Resembles That Observed in Lipopolysaccharide Tolerance

MINOU ADIB-CONQUY CHRISTOPHE ADRIE Pierre Moine Karim Asehnoune CATHERINE FITTING Michael R. Pinsky JEAN-FRANÇOIS DHAINAUT JEAN-MARC CAVAILLON

American Review of Respiratory Disease Vol. 162 No. 5 pp. 1877-1883 · Oxford University Press (OUP)

View at Publisher Save 10.1164/ajrccm.162.5.2003058

Abstract

Abstract
The expression of NF- κ B was studied in freshly isolated peripheral blood mononuclear cells (PBMC) of patients with severe sepsis and major trauma. The expression of p65p50 heterodimer, the active form of NF- κ B, was significantly reduced for all patients as compared with control subjects. The p50p50 homodimer, an inhibitory form of NF- κ B, was reduced in the survivors of sepsis and in patients with trauma. Subsequent in vitro stimulation of PBMC with lipopolysaccharide (LPS) did not induce further NF- κ B nuclear translocation: the survivors of sepsis and trauma patients showed low expression of both p65p50 and p50p50, whereas nonsurvivors of sepsis showed a predominance of the inactive homodimer and a low p65p50/p50p50 ratio when compared with control subjects. In the later group of patients there was a reverse correlation between plasma IL-10 levels and the p65p50/p50p50 ratio after in vitro LPS stimulation (r = − 0.8, p = 0.04). The reduced expression of nuclear NF- κ B was not due to its inhibition by I κ B α, as very low expression of I κ B α, as well as low levels of p65 and p50 were found in the cytoplasm of PBMC from patients with sepsis and trauma when compared with control subjects. These results demonstrate that upon LPS activation, PBMC of patients with systemic inflammatory response syndrome show patterns of NF- κ B expression that resemble those reported during LPS tolerance: global down-regulation of NF- κ B in survivors of sepsis and trauma patients and the presence of large amounts of the inactive homodimer in the nonsurvivors of sepsis.

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Sepsis: A New Hypothesis for Pathogenesis of the Disease Process

Roger C. Bone, Charles J. Grodzin, Robert A. Balk

Chest 1997 10.1378/chest.112.1.235

[2]

Muñoz "Dysregulation of in vitro cytokine production by monocytes during sepsis." J Clin Invest (1991) 10.1172/jci115493

[3]

Van Deuren "Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections." J Infect Dis (1994) 10.1093/infdis/169.1.157

[4]

Marchant "Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock." J Clin Immunol (1995) 10.1007/bf01540884

[5]

Luger "Decreased serum interleukin-1 activity and monocytes interleukin-1 production in patients with fatal sepsis." Crit Care Med (1986) 10.1097/00003246-198605000-00004

[6]

[7]

Astiz "Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis." J Lab Clin Med (1996) 10.1016/s0022-2143(96)90132-8

[8]

Cabié "Influence of surgery on in-vitro cytokine production by human monocytes." Cytokine (1992) 10.1016/1043-4666(92)90022-j

[9]

Kleinschmidt "Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline." Shock (1998) 10.1097/00024382-199801000-00002

[10]

Faist "Alteration of monocyte function following major injury." Arch Surg (1988) 10.1001/archsurg.1988.01400270021002

[11]

McCall "Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome." J Clin Invest (1993) 10.1172/jci116306

[12]

Marie "Reduced ex vivo interleukin-8 production by neutrophils in septic and non-septic systemic inflammatory response syndrome." Blood (1998) 10.1182/blood.v91.9.3439

[13]

Wood "Inadequate interleukin 2 production: a fundamental immunological deficiency in patients with major burns." Ann Surg (1984) 10.1097/00000658-198409000-00008

[14]

Muret "Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures." Shock (2000) 10.1097/00024382-200003000-00001

[15]

Brune "Downregulation of T helper type I immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparascopic surgery." Am J Surg (1999) 10.1016/s0002-9610(98)00299-2

[16]

Takasuka "Supression of TNFα mRNA expression in LPS primed macrophages occurs at the level of NF-κB activation, but not at the level of protein kinase C or CD14 expression." J Immunol (1995) 10.4049/jimmunol.154.9.4803

[17]

Blackwell "Induction of endotoxin tolerance depletes nuclear factor-κB and suppresses its activation in rat alveolar macrophages." J Leukocyte Biol (1997) 10.1002/jlb.62.6.885

[18]

Blackwell "Impaired activation of nuclear factor-κB in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation." J Immunol (1997) 10.4049/jimmunol.158.12.5934

[19]

The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.

M.L. Schmitz, P.A. Baeuerle

The EMBO Journal 1991 10.1002/j.1460-2075.1991.tb04950.x

[20]

Ballard "The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and target for v-Rel-mediated repression." Proc Natl Acad Sci USA (1992) 10.1073/pnas.89.5.1875

[21]

Franzoso "The candidate oncoprotein Bcl-3 is antagonist of p50/NF-κB-mediated inhibition." Nature (1992) 10.1038/359339a0

[22]

Ryseck "RelB, a new Rel family transcription activator that can interact with p50-NF-κB." Mol Cell Biol (1992)

[23]

Moore "Conservation of transcriptional activation functions of the NF-κB p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae." Mol Cell Biol (1993)

[24]

Fujita "The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers." Genes Dev (1993) 10.1101/gad.7.7b.1354

[25]

Franzoso "The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites." EMBO J (1993) 10.1002/j.1460-2075.1993.tb06067.x

[26]

Ziegler-Heitbrock "Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers." J Biol Chem (1994) 10.1016/s0021-9258(17)32510-3

[27]

Bohuslav "Regulation of an essential innate immune response by the p50 subunit of NF-κB." J Clin Invest (1998) 10.1172/jci3877

[28]

Larue "A labile transcriptional repressor modulates endotoxin tolerance." J Exp Med (1994) 10.1084/jem.180.6.2269

[29]

Wahlstrom "Inhibitory κBα control of nuclear factor-κB is dysregulated in endotoxin tolerant macrophages." Shock (1999) 10.1097/00024382-199904000-00003

[30]

Adib-Conquy "Paradoxical priming effects of IL-10 on cytokine production." Intern Immunol (1999) 10.1093/intimm/11.5.689

[31]

Cavaillon "The nonspecific nature of endotoxin tolerance." Trends Microbiol (1995) 10.1016/s0966-842x(00)88963-5

[32]

Goldring "Hyporesponsiveness to lipopolysaccharide alters the composition of NF-κB binding to the regulatory regions of inducible nitric oxide synthase gene." Eur J Immunol (1998) 10.1002/(sici)1521-4141(199809)28:09<2960::aid-immu2960>3.0.co;2-b

[33]

Böhrer "Role of NFκB in the mortality of sepsis." J Clin Invest (1997) 10.1172/jci119648

[34]

Wang "Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms." J Biol Chem (1995) 10.1074/jbc.270.16.9558

[35]

Marchant "Interleukin-10 production during septicaemia." Lancet (1994) 10.1016/s0140-6736(94)91584-9

[36]

Kohler "The involvement of an LPS inducible IκB kinase in endotoxin tolerance." Bioch Biophys Res Comm (1997) 10.1006/bbrc.1997.6337

[37]

Liu "In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock." J Immunol (1997) 10.4049/jimmunol.159.8.3976

[38]

Ruetten "Effect of calpain inhibitor I, an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat." Br J Pharmacol (1997) 10.1038/sj.bjp.0701180

[39]

Jacobs "Elevated interleukin-1 release by human alveolar macrophages during adult respiratory distress syndrome." Am Rev Respir Dis (1989) 10.1164/ajrccm/140.6.1686

[40]

Fieren "Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis." Eur J Clin Invest (1990) 10.1111/j.1365-2362.1990.tb01883.x

Cited By

133

Endotoxin tolerance: new mechanisms, molecules and clinical significance

Subhra K. Biswas, Eduardo López-Collazo · 2009

Trends in Immunology

The Puzzle of Sepsis

Jane Cunneen, Martina Cartwright · 2004

AACN Clinical Issues: Advanced Prac...

Metrics

133

Citations

40

References

Details

Published: Nov 01, 2000
Vol/Issue: 162(5)
Pages: 1877-1883
License: View

Authors

M

MINOU ADIB-CONQUY

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

C

CHRISTOPHE ADRIE

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

P

Pierre Moine

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

K

Karim Asehnoune

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

C

CATHERINE FITTING

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

M

Michael R. Pinsky

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

J

JEAN-FRANÇOIS DHAINAUT

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

J

JEAN-MARC CAVAILLON

Unité d'Immuno-Allergie, Institut Pasteur, Paris, France; Service de Réanimation Médicale, Hôpital Cochin Port-Royal, Paris, France; Département d'Anesthésie Réanimation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicêtre, France; and Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Cite This Article

MINOU ADIB-CONQUY, CHRISTOPHE ADRIE, Pierre Moine, et al. (2000). NF- κ B Expression in Mononuclear Cells of Patients with Sepsis Resembles That Observed in Lipopolysaccharide Tolerance. American Review of Respiratory Disease, 162(5), 1877-1883. https://doi.org/10.1164/ajrccm.162.5.2003058

NF- κ B Expression in Mononuclear Cells of Patients with Sepsis Resembles That Observed in Lipopolysaccharide Tolerance

You May Also Like